“Patient-Reported Outcomes With Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body in the Phase 3 ARRECTOR Trial”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (March 17, 2025): s525. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/3265.